Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors

被引:60
作者
Samala, Ganesh [1 ]
Devi, Parthiban Brindha [1 ]
Saxena, Shalini [1 ]
Meda, Nikhila [1 ]
Yogeeswari, Perumal [1 ]
Sriram, Dharmarajan [1 ]
机构
[1] Birla Inst Technol & Sci Pilani, Dept Pharm, Hyderabad Campus, Hyderabad 500078, Andhra Pradesh, India
关键词
Tuberculosis; Pantothenate synthetase; Imidazo[2,1-b]thiazole; Benzo[d]imidazo[2,1-b]thiazole; MARINUM; MODEL;
D O I
10.1016/j.bmc.2016.01.059
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present study, we have designed imidazo[2,1-b]thiazole and benzoldlimidazo[2,1-b]thiazole derivatives from earlier reported imidazo[1,2-a]pyridine based Mycobacterium tuberculosis (MTB) pantothenate synthetase (PS) inhibitors. We synthesized thirty compounds and they were evaluated for MTB PS inhibition study, in vitro anti -TB activities against replicative and non-replicative MTB, in vivo activity using Mycobacterium marinum infected Zebra fish and cytotoxicity against RAW 264.7 cell line. Among them compound 2-methyl -N' -(4-p henoxybenzoyl)benzo [d] imidazo [2,1 -b]thiazole-3-carbohydrazide (5bc) emerged as potent compound active against MTB PS with IC50 of 0.53 +/- 0.13 mu M, MIC of 3.53 mu M, 2.1 log reduction against nutrient starved MTB, with 33% cytotoxicity at 50 mu M. It also showed 1.5 log reduction of M. marinum load in Zebra fish at 10 mg/kg. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1298 / 1307
页数:10
相关论文
共 20 条
[1]  
[Anonymous], 2017, Global tuberculosis report
[2]   Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling [J].
Betts, JC ;
Lukey, PT ;
Robb, LC ;
McAdam, RA ;
Duncan, K .
MOLECULAR MICROBIOLOGY, 2002, 43 (03) :717-731
[3]   Priming with a Recombinant Pantothenate Auxotroph of Mycobacterium bovis BCG and Boosting with MVA Elicits HIV-1 Gag Specific CD8+ T Cells [J].
Chapman, Rosamund ;
Shephard, Enid ;
Stutz, Helen ;
Douglass, Nicola ;
Sambandamurthy, Vasan ;
Garcia, Irene ;
Ryffel, Bernhard ;
Jacobs, William ;
Williamson, Anna-Lise .
PLOS ONE, 2012, 7 (03)
[4]   Microplate Alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium [J].
Collins, LA ;
Franzblau, SG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1004-1009
[5]   Structure-Guided Design of Thiazolidine Derivatives as Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors [J].
Devi, Parthiban Brindha ;
Samala, Ganesh ;
Sridevi, Jonnalagadda Padma ;
Saxena, Shalini ;
Alvala, Mallika ;
Salina, Elena G. ;
Sriram, Dharmarajan ;
Yogeeswari, Perumal .
CHEMMEDCHEM, 2014, 9 (11) :2538-2547
[6]   In Vitro Antibacterial and Antifungal Activity of Salicylanilide Benzoates [J].
Kratky, Martin ;
Vinsova, Jarmila ;
Buchta, Vladimir .
SCIENTIFIC WORLD JOURNAL, 2012,
[7]   A High-Throughput Screen against Pantothenate Synthetase (PanC) Identifies 3-Biphenyl-4-Cyanopyrrole-2-Carboxylic Acids as a New Class of Inhibitor with Activity against Mycobacterium tuberculosis [J].
Kumar, Anuradha ;
Casey, Allen ;
Odingo, Joshua ;
Kesicki, Edward A. ;
Abrahams, Garth ;
Vieth, Michal ;
Masquelin, Thierry ;
Mizrahi, Valerie ;
Hipskind, Philip A. ;
Sherman, David R. ;
Parish, Tanya .
PLOS ONE, 2013, 8 (11)
[8]   New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes [J].
Lienhardt, Christian ;
Vernon, Andrew ;
Raviglione, Mario C. .
CURRENT OPINION IN PULMONARY MEDICINE, 2010, 16 (03) :186-193
[9]  
Man J. C. de, 1975, European Journal of Applied Microbiology, V1, P67
[10]   Binding of pyrazole-based inhibitors to Mycobacterium tuberculosis pantothenate synthetase: docking and MM-GB(PB)SA analysis [J].
Ntie-Kang, Fidele ;
Kannan, Srinivasaraghavan ;
Wichapong, Kanin ;
Owono, Luc C. Owono ;
Sippl, Wolfgang ;
Megnassan, Eugene .
MOLECULAR BIOSYSTEMS, 2014, 10 (02) :223-239